Spectrum and Management of Immune Related Adverse Events Due to Immune Checkpoint Inhibitors
Davies M, Russo A. Spectrum and Management of Immune Related Adverse Events Due to Immune Checkpoint Inhibitors. Current Cancer Research 2021, 139-173. DOI: 10.1007/978-3-030-74028-3_7.Peer-Reviewed Original ResearchImmune checkpoint inhibitorsImmune related adverse eventsImmune-related adverse eventsRelated adverse eventsCheckpoint inhibitorsAdverse eventsAnti-PD-1/PD-L1Life-threatening organ failureOrgan systemsManagement of toxicitiesCourse of treatmentDegree of severityPD-L1Organ failureGrade severityRisk factorsClinical practiceImmune systemCancer subtypesModern oncologyCancer treatmentOrgan pathophysiologyBasis of toxicityPresent signsToxicity